Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicita Andreotti

Showing results (161-170 of 236) with videos related to

Pageof 24
Sort By:
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|July 16, 2002
[Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation]Mario Gaudino, Giuseppe Nasso, Roberto Zamparelli, et al.
BMJ (Clinical Research Ed.)|April 18, 2015
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trialsEliano Pio Navarese, Felicita Andreotti, Volker Schulze, et al.
The American Journal of Cardiology|May 6, 2014
Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary interventionEliano Pio Navarese, Mariusz Kowalewski, Felicita Andreotti, et al.
Journal of Thrombosis and Thrombolysis|June 18, 2009
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)Felicita Andreotti, Luciano Agati, Elena Conti, et al.
Metabolites|February 25, 2022
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE StudyMartino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 14, 2021
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsLuis Ortega-Paz, Mattia Galli, Davide Capodanno, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 21, 2003
Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgeryMario Gaudino, Augusto Di Castelnuovo, Roberto Zamparelli, et al.
The International Journal of Cardiovascular Imaging|April 26, 2026
CAPIRE score predicts long-term major cardiac eventsDaniele Andreini, Edoardo Conte, Marco Magnoni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 30, 2009
Predictors of exercise-induced platelet reactivity in patients with chronic stable anginaGiancarla Scalone, Gaetano A Lanza, Gregory A Sgueglia, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 25, 2012
Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trialsEliano Pio Navarese, David Austin, Paul A Gurbel, et al.
Pageof 24

Showing results (161-170 of 236) with videos related to

Sort By:
Pageof 24
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|July 16, 2002
[Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation]Mario Gaudino, Giuseppe Nasso, Roberto Zamparelli, et al.
BMJ (Clinical Research Ed.)|April 18, 2015
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trialsEliano Pio Navarese, Felicita Andreotti, Volker Schulze, et al.
The American Journal of Cardiology|May 6, 2014
Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary interventionEliano Pio Navarese, Mariusz Kowalewski, Felicita Andreotti, et al.
Journal of Thrombosis and Thrombolysis|June 18, 2009
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)Felicita Andreotti, Luciano Agati, Elena Conti, et al.
Metabolites|February 25, 2022
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE StudyMartino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 14, 2021
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsLuis Ortega-Paz, Mattia Galli, Davide Capodanno, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 21, 2003
Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgeryMario Gaudino, Augusto Di Castelnuovo, Roberto Zamparelli, et al.
The International Journal of Cardiovascular Imaging|April 26, 2026
CAPIRE score predicts long-term major cardiac eventsDaniele Andreini, Edoardo Conte, Marco Magnoni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 30, 2009
Predictors of exercise-induced platelet reactivity in patients with chronic stable anginaGiancarla Scalone, Gaetano A Lanza, Gregory A Sgueglia, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 25, 2012
Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trialsEliano Pio Navarese, David Austin, Paul A Gurbel, et al.
Pageof 24